Skip to main content Accessibility help
×
Home
  • Print publication year: 2018
  • Online publication date: January 2018

Chapter 7 - Neurodegenerative Chemosensory Disorders

Related content

Powered by UNSILO
Abele, M., Riet, A., Hummel, T., Klockgether, T., Wullner, U. 2003.Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. Journal of Neurology 250, 14531455.
Adler, C.H., Caviness, J.N., Sabbagh, M.N., et al. 2005. Olfactory testing in Parkinson’s disease and other movement disorders: Correlation with Parkinsonian severity. Movement Disorders 20(Supplement 10), Abs: 231.
Aggarwal, N.T., Bienias, J.L., Bennett, D.A., et al. 2006. The relation of cigarette smoking to incident Alzheimer’s disease in a biracial urban community population. Neuroepidemiology 26(3), 140146.
Ahlskog, J.E., Waring, S.C., Petersen, R.C., et al. 1998. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology 51, 16721677.
Alcalay, R.N., Siderowf, A., Ottman, R., et al. 2011. Olfaction in Parkin heterozygotes and compound heterozygotes: The CORE-PD study. Neurology 76, 319326.
Altinayar, S., Oner, S., Can, S., Kizilay, A., Sarac, K., 2014. Olfactory disfunction and its relation olfactor bulbus volume in Parkinson’s disease. European Review for Medical and Pharmacological Sciences 18(23), 36593664.
Altschuler, E., 1996. Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy. Medical Hypotheses 47(5), 413414.
Ansari, K.A., Johnson, A., 1975. Olfactory function in patients with Parkinson’s disease. Journal of Chronic Diseases 28, 493497.
Antunes, M., Bowler, R.M., Doty, R.L., 2007. San Francisco/Oakland Bay Bridge Welder Study: Olfactory function. Neurology 69, 12781284.
Armstrong, C., Harrison, W.T., 1935. Prevention of intranasally-inoculated poliomyelitis of monkeys by instillation of alum into the nostrils. Public Health Reports 50, 725730.
Arriagada, P.V., Louis, D.N., Hedley-Whyte, E.T., Hyman, B.T., 1991. Neurofibrillary tangles and olfactory dysgenesis. Lancet 337, 559.
Ascherio, A., Chen, H., Weisskopf, M.G., et al. 2006. Pesticide exposure and risk for Parkinson’s disease. Annals of Neurology 60, 197203.
Attems, J., Lintner, F., Jellinger, K.A., 2005. Olfactory involvement in aging and Alzheimer’s disease: an autopsy study. Journal of Alzheimer’s Disease 7(2), 149157.
Bacon, A.W., Bondi, M.W., Salmon, D.P., Murphy, C., 1998. Very early changes in olfactory functioning due to Alzheimer’s disease and the role of apolipoprotein E in olfaction. Annals of the New York Academy of Sciences 855, 723731.
Bahar-Fuchs, A., Moss, S., Rose, C., Savage, G., 2010. Olfactory performance in AD, aMCI, and healthy aging: A unirhinal approach. Chemical Senses 35, 855862.
Bak, T.H., Chandran, S., 2011. What wires together dies together: Verbs, actions and neurodegeneration in motor neuron disease. Cortex 48, 936944.
Baker, K.B., Montgomery, E.B. Jr, 2001. Performance on the PD test battery by relatives of patients with progressive supranuclear palsy. Neurology 56, 2530.
Bakija-Konsuo, A., Mulic, R., Boraska, V., et al. 2011. Leprosy epidemics during history increased protective allele frequency of PARK2/PACRG genes in the population of the Mljet Island, Croatia. European Journal of Medical Genetics 54, e548e552.
Ball, M.J., Nuttall, K., 1980. Neurofibrillary tangles granulovacuolar degeneration and neuron loss in Down’s syndrome: Quantitative comparison with Alzheimer’s dementia. Annals of Neurology 7, 462465.
Ballard, C., Ziabreva, I., Perry, R., et al. 2006. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 67, 19311934.
Bannier, S., Berdague, J.L., Rieu, I., et al. 2012. Prevalence and phenomenology of olfactory hallucinations in Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 83, 10191021.
Barnett, E.M., Cassell, M.D., Perlman, S., 1993. Two neurotropic viruses, herpes simplex virus type 1 and mouse hepatitis virus, spread along different neural pathways from the main olfactory bulb. Neuroscience 57, 10071025.
Barrios, F.A., Gonzalez, L., Favila, R., et al. 2007. Olfaction and neurodegeneration in HD. Neuroreport 18, 7376.
Bar-Sela, S., Reingold, S., Richter, E.D., 2001. Amyotrophic lateral sclerosis in a battery-factory worker exposed to cadmium. International Journal of Occupational and Environmental Health 7, 109.
Barz, S., Hummel, T., Pauli, E., et al. 1997. Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson’s disease. Neurology 49, 14241431.
Beach, T.G., White, C.L. 3rd, Hladik, C.L., et al. 2009. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathologica 117(2), 169174.
Beavan, M., McNeill, A., Proukakis, C., et al. 2015. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort. JAMA Neurology 72, 201208.
Bedard, A., Parent, A., 2004. Evidence of newly generated neurons in the human olfactory bulb. Developmental Brain Research 151, 159168.
Belluscio, L., Gold, G.H., Nemes, A., Axel, R., 1998. Mice deficient in G(olf) are anosmic. Neuron 20, 6981.
Belzunegui, S., Sebastian, W.S., Garrido-Gil, P., 2007. The number of dopaminergic cells is increased in the olfactory bulb of monkeys chronically exposed to MPTP. Synapse 61, 10061012.
Berendse, H.W., Roos, D.S., Raijmakers, P., Doty, R.L., 2011. Motor and non-motor correlates of olfactory dysfunction in Parkinson’s disease. Journal of the Neurological Sciences 310, 2124.
Berger, P.C., Vogel, F.S., 1973. The development of the pathologic changes of Alzheimer’s disease and senile dementia in patients with Down’s syndrome. American Journal of Pathology 73, 457476.
Bessen, R.A., Shearin, H., Martinka, S., et al. 2010. Prion shedding from olfactory neurons into nasal secretions. PLoS Pathogens 6, e1000837.
Bessen, R.A., Wilham, J.M., Lowe, D., Watschke, C.P., Shearin, H., Martinka, S., Caughey, B., Wiley, J.A., 2011. Accelerated shedding of prions following damage to the olfactory epithelium. Journal of Virology 86(3), 17771788.
Betarbet, R., Sherer, T.B., MacKenzie, G., et al. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson’s disease. Nature Neuroscience 3, 13011306.
Boesveldt, S., Verbaan, D., Knol, D.L., et al. 2008. A comparative study of odor identification and odor discrimination deficits in Parkinson’s disease. Movement Disorders 23, 19841990.
Boeve, B.F., Silber, M.H., Parisi, J.E., et al. 2003. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 61, 4045.
Bogerts, B., Hantsch, J., Herzer, M., 1983. A Morphometric Study of the Dopamine-Containing Cell Groups in the Mesencephalon of Normals, Parkinson Patients, and Schizophrenics. Biological Psychiatry 18, 951969.
Bohnen, N.I., Gedela, S., Herath, P., Constantine, G.M., Moore, R.Y., 2008. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity. Neuroscience Letters 447, 1216.
Bohnen, N.I., Gedela, S., Kuwabara, H., et al. 2007. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease. Journal of Neurology 254, 8490.
Bohnen, N.I., Muller, M.L., Kotagal, V., et al. 2010. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson’s disease. Brain 133, 17471754.
Bond, J.A., 1986. Bioactivation and biotransformation of xenobiotics in rat nasal tissue. In: Toxicology of the Nasal Passages. Ed. Barrow, C.S.. Washington DC: Hemisphere Publishing Corporation pp. 249261.
Bostantjopoulou, S., Katsarou, Z., Papadimitriou, A., et al. 2001. Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Movement Disorders 16, 10071013.
Bovi, T., Antonini, A., Ottaviani, S., et al. 2010. The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism. Journal of Neurology 257, 18821889.
Bower, J.H., Maraganore, D.M., Peterson, B.J., Ahlskog, J.E., Rocca, W.A., 2006. Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study. Neurology 67, 494496.
Braak, H., Braak, E., 1991. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 82(4), 239259.
Braak, H., Braak, E., 1998. Evolution of neuronal changes in the course of Alzheimer’s disease. Journal of Neural Transmission 53, 127140.
Braak, H., de Vos, R.A., Bohl, J., Del Tredici, K., 2006. Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neuroscience Letters 396(1), 6772.
Braak, H., Del Tredici, K., 2011. The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathologica 121, 171181.
Braak, H., Del Tredici, K., Rub, U., et al. 2003a. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging 24, 197–211.
Braak, H., Rub, U., Gai, W.P., Del Tredici, K. 2003b. Idiopathic Parkinson’s disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. Journal of Neural Transmission 110, 517536.
Braak, H., Thal, D.R., Ghebremedhin, E., Del, T.K., 2011. Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. Journal of Neuropathology and Experimental Neurology 70, 960969.
Braga-Neto, P., Felicio, A.C., Pedroso, J.L., et al. 2011. Clinical correlates of olfactory dysfunction in spinocerebellar ataxia type 3. Parkinsonism & Related Disorders 17, 353356.
Branco Germiniani, F., Cavalcante, T., Moro, A., et al. 2014. Evaluation of olfactory function in Friedreich’s ataxia: A case-control study. European Journal of Neurology 21, 175175.
Brittebo, E.B., Eriksson, V.F., Bakke, J., Brandt, I., 1991. Toxicity of 2 6-dichlorothiobenzamide (Chlorthiamid) and 2 6-dichlorobenzamide in the olfactory nasal mucosa of mice. Fundamental and Applied Toxicology 17, 92102.
Brodoehl, S., Klingner, C., Volk, G.F., et al. 2012. Decreased olfactory bulb volume in idiopathic Parkinson’s disease detected by 3.0-Tesla magnetic resonance imaging. Movement Disorders 27, 10191025.
Broggio, E., Pluchon, C., Ingrand, P., Gil, R., 2001. Taste impairment in Alzheimer’s disease. Revue Neurologique 157(4), 409413.
Brousseau, K., Brainerd, H.G., Mongolism: A Study of the Physical and Mental Characteristics of Mongolian Imbeciles. Baltimore: Williams and Wilkins. 1928.
Busenbark, K.L., Huber, S.J., Greer, G., Pahwa, R., Koller, W.C., 1992. Olfactory function in essential tremor. Neurology 42, 16311632.
Buxton, P.H., Hayward, M., 1967. Polyneuritis cranialis associated with industrial trichloroethylene exposure. Journal of Neurology, Neurosurgery, & Psychiatry 30, 511518.
Bylsma, F.W., Moberg, P.J., Doty, R.L., Brandt, J., 1997. Odour identification in Huntington’s disease patients and their offspring with and without the genetic mutation for HD. Journal of Neuropsychology and Clinical Neuroscience 9, 598600
Calderón-Garcidueñas, L., Reed, W., Maronpot, R.R., et al. 2004. Brain inflammation and Alzheimer’s-like pathology in individuals exposed to severe air pollution. Toxicologic Pathology 32(6), 650658.
Calderón-Garcidueñas, L., Franco-Lira, M., Henríquez-Roldán, C., et al. 2010. Urban air pollution: Influences on olfactory function and pathology in exposed children and young adults. Experimental and Toxicologic Pathology 62(1), 91102.
Charles, P.C., Walters, E., Margolis, F., Johnston, R.E., 1995. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology 208, 662671.
Chen, M.A., Lander, T.R., Murphy, C., 2006. Nasal health in Down syndrome: A cross-sectional study. Otolaryngology – Head and Neck Surgery 134, 741745.
Chen, S., Tan, H.Y., Wu, Z.H., et al. 2014. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson’s disease and multiple system atrophy. European Journal of Radiology 83, 564570.
Connelly, T., Farmer, J., Lunch, D., Doty, R.L., 2003. Olfactory dysfunction in degenerative ataxias. Journal of Neurology, Neurosurgery, & Psychiatry 74(10), 14351437.
Constantinidis, J., de Ajuriaguerra, J., 1970. Syndrome familial avec tremblement parkin-sonien et anosmie et sa thérapeutique par la L-dopa associée à un inhibiteur de la decarboxylase. Thérapeutique (Semaine des Hôpitaux), 46, 263269.
Crino, P.B., Martin, J.A., Hill, W.D., et al. 1995. Beta-amyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer’s disease Parkinson’s disease and Down syndrome. Annals of Otology, Rhinology, and Laryngology 104, 655661.
Dahl, A.R., 1986. Possible consequences of cytochrome P-450 dependent monooxygenases in nasal tissues. In: Toxicology of the Nasal Passages. Ed. Barrow, C.S. Hemisphere Publishing Corporation. Washington D.C.; 263273.
Dahl, A.R., 1988. The effect of cytochrome P-450-dependent metabolism and other enzyme activities in olfaction. In: Molecular Neurobiology of the Olfactory System. Eds. Margolis, F.L., Getchell, T.V. Plenum press. New York; 5170.
Daniel, S.E., Hawkes, C.H., 1992. Preliminary diagnosis of Parkinson’s disease by olfactory bulb pathology [letter]. Lancet 340, 186.
Daum, R.F., Sekinger, B., Kobal, G., Lang, C.J., (2000) Riechprufung mit “sniffin’ sticks” zur klinischen Diagnostik des Morbus Parkinson. Nervenarzt 71, 643650.
Deeb, J., Shah, M., Muhammed, N., et al. 2010. A basic smeel test is as sensitive as a dopamine transporter scan: Comparison of olfaction, taste and DaTSCAN in the diagnosis of Parkinson’s disease. QJM 103, 941952.
Del Tredici, K., Hawkes, C.H., Ghebremedhin, E., Braak, H., 2010. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathologica 119, 703713.
Devanand, D.P., Liu, X., Tabert, M.H., et al. 2008. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer’s disease. Biological Psychiatry 64(10), 871879.
Devanand, D.P., Michaels-Marston, K.S., Liu, X., et al. 2000. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. American Journal of Psychiatry 157, 13991405.
Diaz-Maroto, M.C., Perez-Coello, M.S., Cabezudo, M.D., 2002. Headspace solid-phase microextraction analysis of volatile components of spices. Chromatographia, 55, 723728.
Ding Xie, F., 2015, Olfactory mucosa: Composition, enzymatic localization, and metabolism. In Doty, R.L., (Ed.), Handbook of Olfaction and Gustation. Hoboken: John Wiley & Sons, pp. 6391.
Djaldetti, R., Nageris, B.I., Lorberboym, M., et al. 2008 [(123)I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor. Journal of Neural Transmission 115: 469472.
Doty, R.L., 1991, Olfactory dysfunction in neurodegenerative disorders. In: Getchell, T.V., Doty, R.L., Bartoshuk, L.M., Snow, J.B. Jr Smell and Taste in Health and Disease. New York: Raven Press, pp. 735752.
Doty, R.L., 2001, Olfaction. Annual Review of Psychology 52, 423452.
Doty, R.L., 2008. The olfactory vector hypothesis of neurodegenerative disease: Is it viable? Annals of Neurology 63, 715.
Doty, R.L., 2015a. Neurotoxic exposure and impairment of the chemical senses of taste and smell. Handbook of Clinical Neurology 131, 299324.
Doty, R.L., 2015b (Ed.), Handbook of Olfaction and Gustation. Hoboken: John Wiley & Sons.
Doty, R.L., 2017. Olfactory dysfunction in neurological diseases: Is there a common pathological substrate? Lancet Neurology 16, 478488.
Doty, R.L., Bayona, E.A., Leon-Ariza, D.S., et al. 2014. The lateralized smell test for detecting Alzheimer’s disease: Failure to replicate. Journal of the Neurological Sciences 340, 170173.
Doty, R.L., Bromley, S.M., Moberg, P.J., Hummel, T., 1997. Laterality in human nasal chemoreception. Chapter 14. In: Christman, S. (Ed.), Cerebral Asymmetries in Sensory and Perceptual Processing. Elsevier, pp. 497542.
Doty, R.L., Deems, D.A., Stellar, S., 1988. Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology, 38, 12371244.
Doty, R.L., Golbe, L.I., McKeown, D.A., et al. 1993. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson’s disease. Neurology, 43, 962965.
Doty, R.L., Hawkes, C.H., Good, K.P., Duda, J.E., 2015. Odor perception and neuropathology in neurodegenerative diseases and schizophrenia. In: Doty, R.L. (Ed.), Handbook of Olfaction and Gustation. 3rd edition. Hoboken, NJ: John Wiley & Sons, pp. 403451.
Doty, R.L., Nsoesie, M.T., Chung, I., et al. 2015. Taste function in early stage treated and untreated Parkinson’s disease. Journal of Neurology 262, 547557.
Doty, R.L., Perl, D.P., Steele, J.C., et al. 1991a. Odor identification deficit of the parkinsonism-dementia complex of Guam: Equivalence to that of Alzheimer’s and idiopathic Parkinson’s disease. Neurology 41, 7780.
Doty, R.L., Reyes, P.F., Gregor, T., 1987, Presence of both odor identification and detection deficits in Alzheimer’s disease. Brain Research Bulletin 18, 597600.
Doty, R.L., Riklan, M., Deems, D.A., Reynolds, C., Stellar, S., 1989. The olfactory and cognitive deficits of Parkinson’s disease: Evidence for independence. Annals of Neurology 25, 166171.
Doty, R.L., Shaman, P., Applebaum, S.L., et al. 1984. Smell identification ability: Changes with age. Science 226, 14411443.
Doty, R.L., Stern, M.B., Pfeiffer, C., Gollomp, S.M., Hurtig, H.I., 1992a. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 55, 138142.
Doty, R.L., Singh, A., Tetrud, J., Langston, J.W., 1992b. Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Annals of Neurology 32, 97100.
Doty, R.L., Tourbier, I., Ng, V., et al. 2015. Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women. Neurobiology of Aging 36(6), 20532059.
Double, K.L., Rowe, D.B., Hayes, M., et al. 2003. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Archives of Neurology 60, 545549.
Driver-Dunckley, E., Adler, C.H., Hentz, J.G., et al. 2014. Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease. Parkinsonism & Related Disorders 20, 12601262.
Duda, J.E., Noorigian, J.V., Petrovitch, H., White, L.R., Ross, W.R., 2007. Pattern of Lewy body progression suggested Braak staging system is supported by analysis of a population based cohort of patients. Movement Disorders 22: Suppl 16, LB5 (late breaking abstract).
Duda, J.E., Shah, U., Arnold, S.E., Lee, V.M., Trojanowski, J.Q., 1999. The expression of alpha- beta- and gamma-synucleins in olfactory mucosa from patients with and without neurodegenerative diseases. Experimental Neurology 160: 515522.
Duff, K., McCaffrey, R.J., Solomon, G.S., 2002. The Pocket Smell Test: Successfully discriminating probable Alzheimer’s dementia from vascular dementia and major depression. Journal of Neuropsychiatry and Clinical Neurosciences, 14(2), 197201.
Dunn, L.M., 1981. Peabody Picture Vocabulary Test-Revised Manual for Forms L and M. American Guidance Service: Circle Pines, MN.
Dziewulska, D., Doi, H., Fasano, A., et al. 2013. Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation. Acta Neuropathologica 126, 151153.
Eggers, C., Schmidt, A., Hagenah, J., et al. 2010. Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit. Neurology 74, 17981805.
Elbaz, A., Levecque, C., Clavel, J., et al. 2004. CYP2D6 polymorphism pesticide exposure and Parkinson’s disease. Annals of Neurology 55(3), 430434.
Elian, M., 1991. Olfactory impairment in motor neuron disease: a pilot study. Journal of Neurology, Neurosurgery, & Psychiatry 54, 927–8
Esiri, M.M., 1991. Pathology of the olfactory and taste systems. In: Getchell, T.V., Doty, R.L., Bartoshuk, L.M., Snow, J.B. Jr Smell and Taste in Health and Disease. N.Y.: Raven Press, pp. 683701.
Evidente, V.G., Esteban, R.P., Hernandez, J.L., et al. 2004. Smell testing is abnormal in “lubag” or X-linked dystonia-parkinsonism: A pilot study. Parkinsonism & Related Disorders 10, 407410.
Faber, H.K., Silverberg, R.J., 1946. A neuropathological study of acute human polio-myelitis with special reference to the inidtial lesio and various potential portals of entry. Journal of Experimental Medicine 83, 329353.
Fearnley, J.M., Lees, A.J., 1991. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114, 22832301.
Fernandez-Ruiz, J., Diaz, R., Hall-Haro, C., et al. 2003. Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport 14(10), 13391341.
Ferraris, A., Ialongo, T., Passali, G.C., et al. 2009. Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Movement Disorders 24(16), 23502357.
Ferreira, J.J., Guedes, L.C., Rosa, M.M., et al. 2007. High prevalence of LRRK2 mutations in familial and sporadic Parkinson’s disease in Portugal. Movement Disorders, 22, 11941201.
Ferreyra-Moyano, H., Barragan, E., 1989. The olfactory system and Alzheimer’s disease. International Journal of Neuroscience 49, 157197.
Fleming, S.M., Tetreault, N.A., Mulligan, C.K., et al. 2008. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. European Journal of Neuroscience 28, 247256.
Flexner, S., Clark, P.F., 1912. A note on the mode of infection in epidemic poliomyelitis. Proceedings of the Society for Experimental Biology & Medicine 10, 12.
Flexner, S., Lewis, P.A., 1910. Experimental epidemic poliomyelitis in monkeys. Journal of Experimental Medicine 12, 227255.
Funabe, S., Takao, M., Saito, Y., et al. 2013. Neuropathologic analysis of Lewy-related alpha-synucleinopathy in olfactory mucosa. Neuropathology 33, 4758.
Gadoth, N., Mass, E., Gordon, C.R., Steiner, J.E., 1997. Taste and smell in familial dysautonomia. Developmental Medicine and Child Neurology 39, 393397.
Galvin, J.E., Pollack, J., Morris, J.C., 2006. Clinical phenotype of Parkinson disease dementia. Neurology 67, 16051611.
Gardiner, J., Barton, D., Vanslambrouck, J.M., et al. 2008. Defects in tongue papillae and taste sensation indicate a problem with neurotrophic support in various neurological diseases. Neuroscientist 14, 240250.
Garland, E.M., Raj, S.R., Peltier, A.C., Robertson, D., Biaggioni, I., 2011. A cross-sectional study contrasting olfactory function in autonomic disorders. Neurology 76, 456460.
Genter, M.B., Krishan, M., Preditor, R.D., 2015. The olfactory system as a route of delivery for agents to the brain and circulation. In: Doty, R.L. (Ed.), Handbook of Olfaction and Gustation. 3rd edition. Hoboken, NJ: John Wiley & Sons, pp. 453484.
Geser, F., Wenning, G.K., Poewe, W., McKeith, I., 2005. How to diagnose dementia with Lewy bodies: state of the art. Movement Disorders 20 Suppl 12, S1120.
Ghadami, M., Majidzadeh, A., Morovvati, S., et al. 2004. Isolated congenital anosmia with morphologically normal olfactory bulb in two Iranian families: A new clinical entity? American Journal of Medical Genetics Part A 127A, 307309.
Gilbert, P.E., Murphy, C., 2004. The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer’s disease, probable Alzheimer’s disease, and healthy elderly controls. Journal of Clinical Experimental Neuropsychology 26, 779794.
Gillner, M., Brittebo, E.B., Brandt, I., Soderkvist Appelgren, L-E., Gustafsson, J-A., 1987. Uptake and specific binding of 2 3 7 8-tetrachlorodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Research 47, 41504159.
Glasl, L., Kloos, K., Giesert, F., et al. 2012. Pink1-deficiency in mice impairs gait, olfaction and serotonergic innervation of the olfactory bulb. Experimental Neurology 235, 214227.
Glass, P.G., Lees, A.J., Mathias, C., Mason, L., Best, C., Williams, D.R., Katzenschlager, R., Silveira‐Moriyama, L., et al. 2011. Olfaction in pathologically proven patients with multiple system atrophy. Movement Disorders 27(2), 327328.
Goetz, C.G., Stebbins, G.T., Ouyang, B., 2011. Visual plus nonvisual hallucinations in Parkinson’s disease: Development and evolution over 10 years. Movement Disorders 26, 21962200.
Goetz, C.G., Vogel, C., Tanner, C.M., Stebbins, G.T., 1998. Early dopaminergic drug-induced hallucinations in parkinsonian patients. Neurology 51, 811814.
Goker-Alpan, O., Lopez, G., Vithayathil, J., et al. 2008. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Archives of Neurology 65, 13531357.
Goldstein, D.S., Sewell, L., 2009. Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases. Parkinsonism & Related Disorders 15(7), 516520.
Goldstein, D.S., Holmes, C., Bentho, O., et al. 2008. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism & Related Disorders 14, 600607.
Gottofrey, J., Tjalve, H., 1991. Axonal transport of cadmium in the olfactory nerve of the pike. Pharmacology & Toxicology 69, 242252.
Graves, A.B., Bowen, J.D., Rajaram, L., et al. 1999. Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E epsilon4 status. Neurology 53, 14801487.
Gray, A.J., Staples, V., Murren, K., Dhariwal, A., Bentham, P., 2001. Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. International Journal of Geriatric Psychiatry 16(5), 513517.
Gray, J.M., Young, A.W., Barker, W.A., Curtis, A., Gibson, D., 1997. Impaired recognition of disgust in Huntington’s disease gene carriers. Brain 120(Pt 11), 20292038.
Gresham, L.S., Molgaard, C.A., Smith, R.A., 1993. Induction of cytochrome P-450 enzymes via tobacco smoke: A potential mechanism for developing resistance to environmental toxins as related to parkinsonism and other neurologic diseases. Neuroepidemiology 12(2), 114116.
Haehner, A., Hummel, T., Hummel, C., et al. 2007. Olfactory loss may be a first sign of idiopathic Parkinson’s disease. Movement Disorders 22, 839842.
Hague, K., Lento, P., Morgello, S., Caro, S., Kaufmann, H., 1997. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol 94, 192196.
Halliday, G., Del Tredici, K., Braak, H., 2006. Critical appraisal of the Braak staging of brain pathology related to sporadic Parkinson’s disease. Journal of Neural Transmission Suppl 70, 99103.
Halliday, G.M., Barker, R.A., Rowe, D.B., 2011. Non-dopamine Lesions in Parkinson’s Disease. Oxford: Oxford University Press.
Hamilton, J.M., Murphy, C., Paulsen, J.S., 1999. Odour detection learning and memory in Huntington’s disease. Journal of the International Neuropsychological Society 5, 609615.
Hamir, A.N., Kunkle, R.A., Richt, J.A., Miller, J.M., Greenlee, J.J., 2008. Experimental transmission of US scrapie agent by nasal, peritoneal, and conjunctival routes to genetically susceptible sheep. Veterinary Pathology 45, 711.
Handley, O.J., Morrison, C.M., Miles, C., Bayer, A.J., 2006. ApoE gene and familial risk of Alzheimer’s disease as predictors of odour identification in older adults. Neurobiology of Aging 27, 14251430.
Hardy, J., 2005. Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: “Permissive templating” as a general mechanism underlying neurodegeneration. Biochemical Society Transactions 33, 578581.
Hawkes, C.H., Shephard, B.C., 1992. Olfactory impairment in Parkinson’s disease: Evidence of dysfunction measured by olfactory event-related potentials and smell identification tests. Annals of Neurology 32, 248 (abstract).
Hawkes, C.H., Shephard, B.C., 1993, Selective anosmia in Parkinson’s disease? Lancet Neurology 341, 435436.
Hawkes, C.H., Shephard, B.C., 1998. Olfactory evoked responses and identification tests in neurological disease. Annals of New York Academy of Science 855, 608615.
Hawkes, C., Shah, M., Fogo, A., 2005. Smell identification declines from age 36 years and mainly affects pleasant odours. Movement Disorders 20 (Suppl. 10) S48. P160 (abstract).
Hawkes, C.H., Del Tredici, K, Braak, H., 2007. Parkinson’s disease: A dual-hit hypothesis. Neuropathology and Applied Neurobiology 33(6), 599614.
Hawkes, C.H., 2008a. Parkinson’s disease and aging: same or different process? Movement Disorders 23(1), 4753.
Hawkes, C.H., 2008b. The prodromal phase of sporadic Parkinson’s disease: Does it exist and if so how long is it? Movement Disorders 23, 17991807.
Hawkes, C.H., Del Tredici, K., Braak, H., 2010. A timeline for Parkinson’s disease. Parkinsonism & Related Disorders 16, 7984.
Hawkes, C.H., Shephard, B.C., Daniel, SE. (1997). Olfactory dysfunction in Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 62, 436436.
Hayes, C.J., Stevenson, R.J., Coltheart, M., 2007. Disgust and Huntington’s disease. Neuropsychologia 45, 11351151.
Hemdal, P., Corwin, J., Oster, H., 1993. Olfactory identification deficits in Down’s syndrome and idiopathic mental retardation. Neuropsychologia 31, 977984.
Hensiek, A.E., Bhatia, K., Hawkes, C.H., 2000. Olfactory function in drug induced parkinsonism. Journal of Neurology 247(3), 303.
Hentschel, K., Baba, Y., Williams, L.N., et al. 2005. Olfaction in familial parkinsonism (FP). Movement Disorders 20, P175, S52S52.
Hext, P.M., Lock, E.A., 1992. The accumulation and metabolism of 3-trifluoromethylpyridine by rat olfactory and hepatic tissues. Toxicology 72, 6175.
Höglinger, G.U., Alvarez-Fischer, D., Arias-Carrión, O., et al. 2015. A new dopaminergic nigro-olfactory projection. Acta neuropathologica 130(3), 333348.
Holter, S.M., Stromberg, M., Kovalenko, M., et al. 2013. A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington’s disease CAG knock-in mice. PLoS One 8, e80923.
Hozumi, S., Nakagawasai, O., Tan-No, K., Niijima, F., Yamadera, F., Murata, A., Arai, Y., Yasuhara, H., Tadano, T., 2003. Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behavioural Brain Research 138(1), 915.
Huart, C., Rombaux, P., Gérard, T., Hanseeuw, B., Lhommel, R., Quenon, L., Ivanoiu, A., Mouraux, A., 2015. Unirhinal olfactory testing for the diagnostic workup of mild cognitive impairment. Journal of Alzheimer’s Disease 47(1), 253270.
Hughes, A.J., Daniel, S.E., Lees, A.J. 2001. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Neurology 57(8), 14971499.
Huisman, E., Uylings, H.B, Hoogland, P.V., 2004. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson’s disease. Movement Disorders 19, 687692.
Huisman, E., Uylings, HB., Hoogland, PV., 2008. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson’s disease patients. Movement Disorders 23, 14071413.
Iijima, M., Osawa, M., Momose, M., et al. 2010. Cardiac sympathetic degeneration correlates with olfactory function in Parkinson’s disease. Movement Disorders 25(9), 11431149.
Imamura, K., Matumoto, S., Mabuchi, N., et al. 2009. Relationship between the regional cerebral blood flow and the cognitive function and anosmia in patients with Parkinson disease and Alzheimer disease. Brain Nerve 61(6), 683690.
Iranzo, A., Molinuevo, J.L., Santamaria, J., et al. 2006. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: A descriptive study. Lancet Neurology 5, 572577.
Iscan, M., Reuhl, K., Weiss, B., Maines, M.D., 1990. Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: The olfactory bulb and the mitrochondrial fraction have high levels of activity. Biochemical and Biophysical Research Communications 169, 858863.
Jellinger, K.A. 2009. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathologica 117(2), 215–6
Jennings, D., Siderowf, A., Stern, M., et al. 2014. Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology 83, 17391746.
Johansen, K.K., White, L.R., Farrer, M.J., Aasly, J.O., 2011. Subclinical signs in LRRK2 mutation carriers. Parkinsonism & Related Disorders 17, 528532.
Juncos, J.L., Lazarus, J.T., Rohr, J., et al. 2012. Olfactory dysfunction in fragile X tremor ataxia syndrome. Movement Disorders 27, 15561559.
Kalaitzakis, M.E., Graeber, M.B., Gentleman, S.M., Pearce, R.K., 2008. The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson’s disease: A critical analysis of alpha-synuclein staging. Neuropathology and Applied Neurobiology 34, 284295.
Kalmey, J.K., Thewissen, J.G., Dluzen, DE. 1998. Age-related size reduction of foramina in the cribriform plate. Anatomical Record 251(3), 326329.
Kandasamy, M., Rosskopf, M., Wagner, K., et al. 2015. Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington’s disease is accompanied by striatal invasion of neuroblasts. PLoS One 10, e0116069.
Kashihara, K., Hanaoka, A., Imamura, T., 2011. Frequency and characteristics of taste impairment in patients with Parkinson’s disease: Results of a clinical interview. Internal Medicine 50(20), 23112315.
Kareken, D.A., Doty, R.L., Moberg, P.J., et al. 2001. Olfactory-evoked regional cerebral blood flow in Alzheimer’s disease. Neuropsychology 15(1), 1829.
Katzman, R., 1986. Alzheimer’s disease. New England Journal of Medicine 314, 964973.
Katzman, R., 1986. Differential diagnosis of dementing illnesses. Neurologic Clinics 4, 329340.
Kaufmann, H., Nahm, K., Purohit, D., Wolfe, D., 2004. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 63, 10931095.
Kertelge, L., Bruggemann, N., Schmidt, A., et al. 2010. Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson’s disease. Movement Disorders 25, 26652669.
Khan, N.L., Katzenschlager, R., Watt, H., et al. 2004. Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease. Neurology 62, 12241226.
Killgore, W.D.S., McBride, S.H., 2006. Odour identification accuracy declines following 24 h of sleep deprivation. J Sleep Res 15, 111116.
Kim, H.J., Jeon, B.S., Lee, J.Y., et al. 2011. Taste function in patients with Parkinson disease. Journal of Neurology 258, 10761079.
Kishikawa, M., Iseki, M., Sakae, M., Kawaguchi, S., Fujii, H., 1994. Early diagnosis of Alzheimer’s? Nature 369(6479), 365366.
Klein, C., Schneider, S.A., Lang, A.E., 2009. Hereditary parkinsonism: Parkinson disease look-alikes–an algorithm for clinicians to “PARK” genes and beyond. Movement Disorders 24(14), 20422058.
Klimek, L., 1998. Sense of smell in allergic rhinitis. Pneumologie 52, 196202.
Knupfer, L., Spiegel, R., 1986. Differences in olfactory test performance between normal aged, Alzheimer and vascular type dementia individuals. International Journal of Geriatric Psychiatry 1(1), 314.
Kobal, G., Plattig, K.H., 1978. [Objective olfactometry: Methodological annotations for recording olfactory EEG-responses from the awake human]. EEG EMG Z eitschrift Fur Elektroenzephalographie, Elektromyographie Und Verwandte Gebiete 9, 135145.
Koss, E., Weiffenbach, J.M., Haxby, J.V., Friedland, R.P., 1988. Olfactory detection and identification performance are dissociated in early Alzheimer’s disease. Neurology 38(8), 12281228.
Kovacs, T., Papp, M.I., Cairns, N.J., Khan, M.N., Lantos, P.L. 2003. Olfactory bulb in multiple system atrophy. Movement Disorders 18, 938942.
Kovacs, G.G., Trabattoni, G., Hainfellner, J.A., et al. 2002. Mutations of the prion protein gene phenotypic spectrum. Journal of Neurology 249, 15671582.
Kovács, T., 2013. The olfactory system in Alzheimer’s disease: Pathology, pathophysiology and pathway for therapy. Translational Neuroscience 4(1), 3445.
Kovacs, T., Cairns, N.J., Lantos, P.L., 2001. Olfactory centres in Alzheimer’s disease: Olfactory bulb is involved in early Braak’s stages. Neuroreport 12, 285288.
Krismer, F., Wenning, G.K., Li, Y., Poewe, W., Stefanova, N. 2013. Intact olfaction in a mouse model of multiple system atrophy. PLoS One, 8, e64625.
Krüger, R., Müller, T., Riess, O., 2000. Involvement of α-synuclein in Parkinson’s disease and other neurodegenerative disorders. Journal of Neural Transmission 107(1), 3140.
Krüger, S., Haehner, A., Thiem, C., Hummel, T. 2008. Neuroleptic-induced parkinsonism is associated with olfactory dysfunction. Journal of Neurology 255(10), 15741579.
Kumar, K.R., Weissbach, A., Heldmann, M., et al. 2012. Frequency of the D620 N mutation in VPS35 in Parkinson disease. Archives of Neurology 69, 13601364.
Kurtenbach, S., Wewering, S., Hatt, H., Neuhaus, E.M., Lubbert, H. 2013., Olfaction in three genetic and two MPTP-induced Parkinson’s disease mouse models. PLoS One 8, e77509.
Landis, B.N., Burkhard, P.R., 2008. Phantosmias and Parkinson disease. Archives of Neurology 65, 12371239.
Lang, C.J., Leuschner, T., Ulrich, K. et al. 2006. Taste in dementing diseases and parkinsonism. Journal of the Neurological Sciences 248, 177184.
Lang, C., Schwandner, K., Hecht, M., 2011. Do patients with motor neuron disease suffer from disorders of taste or smell? Amyotrophic Lateral Sclerosis 12, 368371.
Larson, J., Kim, D., Patel, R.C., Floreani, C., 2008. Olfactory discrimination learning in mice lacking the fragile X mental retardation protein. Neurobiology of Learning and Memory 90, 90102.
Le Pichon, C.E., Valley, M.T., Polymenidou, M., et al. 2009. Olfactory behavior and physiology are disrupted in prion protein knockout mice. Nature Neuroscience 12, 6069.
Lee, D.H., Oh, J.S., Ham, J.H., et al. 2015. Is normosmic Parkinson disease a unique clinical phenotype? Neurology 85(15), 12701275.
Lee, L.V., Munoz, E.L., Tan, K.T., Reyes, M.T., 2001. Sex linked recessive dystonia parkinsonism of Panay, Philippines (XDP). Molecular Pathology 54, 362368.
Lee, P.H., Yeo, S.H., Yong, S.W., Kim, Y.J., 2007. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism. Journal of Neurology, Neurosurgery, & Psychiatry 78, 12501252.
Lehman, C.D., Bartoshuk, L.M., Catalanotto, F.C., Kveton, J.F., Lowlicht, R.A., 1995. Effect of anesthesia of the chorda tympani nerve on taste perception in humans. Physiology & Behavior 57(5), 943–51.
Lelan, F., Boyer, C., Thinard, R., et al. 2011. Effects of Human Alpha-Synuclein A53T-A30P Mutations on SVZ and Local Olfactory Bulb Cell Proliferation in a Transgenic Rat Model of Parkinson Disease. Journal of Parkinson’s Disease 987084.
Lesage, S., Anheim, M., Condroyer, C., et al 1995. French Parkinson’s Disease Genetics Study Group. Large-scale screening of the Gaucher’s disease-related glucocerebrosidase gene in Europeans with Parkinson’s disease. Human Molecular Genetics 2011; 20(1), 202–10.
Lesage, S., Durr, A., Brice, A., 2007. LRRK2: A link between familial and sporadic Parkinson’s disease? Pathologie Biologie (Paris), 55, 107110.
Li, A.A., Mink, P.J., McIntosh, L.J., Teta, M.J., Finley, B., 2005. Evaluation of epidemiologic and animal data associating pesticides with Parkinson’s disease. Occupational and Environmental Medicine 47(10), 10591087.
Liberini, P., Parola, S., Spano, P.F., Antonini, L., 2000. Olfaction in Parkinson’s disease: Methods of assessment and clinical relevance. Journal of Neurology 247, 8896
Liou, H.H., Tsai, M.C., Chen, C.J., et al. 1997. Environmental risk factors and Parkinson’s disease: a case-control study in Taiwan. Neurology 48(6), 15831588.
Lohmann, E., Leclere, L., De Anna, F., et al. 2009. French Parkinson’s Disease Genetics Study Group. A clinical, neuropsychological and olfactory evaluation of a large family with LRRK2 mutations. Parkinsonism & Related Disorders 15(4), 273276.
Louis, E.D., Bromley, S.M., Jurewicz, E.C., Watner, D., 2002. Olfactory dysfunction in essential tremor: A deficit unrelated to disease duration or severity. Neurology, 59(10), 16311633.
Louis, E.D., Jurewicz, E.C., 2003. Olfaction in essential tremor patients with and without isolated rest tremor. Movement Disorders 18(11), 13871389.
Louis, E.D., Rios, E., Pellegrino, K.M., et al. 2008. Higher blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations correlate with lower olfactory scores in essential tremor. Neurotoxicology 29, 460465.
Louis, E.D., Vonsattel, J.P., Honig, L.S., et al. 2006. Neuropathologic findings in essential tremor. Neurology 66(11), 17561759.
Louis, E.D., Faust, P.L., Ma, K.J., et al. 2011. Torpedoes in the Cerebellar Vermis in Essential Tremor Cases vs. Controls. Cerebellum 10, 812819.
Lovell, M.A., Jafek, B.W., Moran, D.T., Rowley, J.C., 1982. Biopsy of human olfactory mucosa: An instrument and a technique. Archives of Otolaryngology 247249.
Lucassen, E.B., Sterling, N.W., Lee, E.Y., et al. 2014. History of smoking and olfaction in Parkinson’s disease. Movement Disorders 29(8), 10691074.
Luzzi, S., Snowden, J.S., Neary, D., Coccia, M., Provinciali, L., Lambon Ralph, M.A., 2007. Distinct patterns of olfactory impairment in Alzheimer’s disease, semantic dementia, frontotemporal dementia, and corticobasal degeneration. Neuropsychologia 45(8), 18231831.
Macknin, J.B., Higuchi, M., Lee, V.M.Y., Trojanowski, J.Q., Doty, R.L., 2004. Olfactory dysfunction occurs in transgenic mice overexpressing human τ protein. Brain Research 1000(1), 174178.
Magerova, H., Vyhnalek, M., Laczo, J., et al. 2014. Odor Identification in Frontotemporal Lobar Degeneration Subtypes. American Journal of Alzheimer’s Disease and Other Dementias.
Mann, D.M., 1988. Alzheimer’s disease and Down’s syndrome. Histopathology 13, 125137.
Mann, D.M., 1989. The pathogenesis and progression of the pathological changes of Alzheimer’s disease. Annals of Medicine 21(2), 133136.
Markesbery, W.R., Jicha, G.A., Liu, H., Schmitt, FA. 2009. Lewy body pathology in normal elderly subjects. Journal of Neuropathology and Experimental Neurology 68, 816822.
Markopoulou, K., Larsen, K.W., Wszolek, E.K., et al. 1997. Olfactory dysfunction in familial parkinsonism. Neurology 49, 12621267.
Marras, C., Goldman, S., Smith, A., et al. 2005. Smell identification ability in twin pairs discordant for Parkinson’s disease. Movement Disorders 20(6), 687693.
Martel, G., Simon, A., Nocera, S., et al. 2015. Aging, but not tau pathology, impacts olfactory performances and somatostatin systems in THY-Tau22 mice. Neurobiology of Aging 36(2), 10131028.
Masucci, MG. 2004.Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system. Oncogene 23, 21072115.
McAuley, J.H., Gregory, S., 2012. Prevalence and clinical course of olfactory hallucinations in idiopathic Parkinson’s disease. Journal of Parkinson’s Disease 2, 199205.
McKeith, I.G., 2006. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop. Journal of Alzheimer’s Disease 9 (3 Suppl), 417423.
McKeown, D.A., Doty, R.L., Perl, D.P., Frye, R.E., Simms, I., Mester, A., 1996. Olfactory function in young adolescents with Down’s syndrome. Journal of Neurology, Neurosurgery, & Psychiatry 61, 412414.
McLaughlin, N.C., Westervelt, H.J., 2008. Odor identification deficits in frontotemporal dementia: a preliminary study. Archives of Clinical Neuropsychology 23(1), 119123.
McNeill, A., Duran, R., Proukakis, C., et al. 2012. Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Movement Disorders 27, 526532.
McShane, R.H., Nagy, Z., Esiri, M.M., et al. 2001. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer’s pathology. Journal of Neurology, Neurosurgery, & Psychiatry 70, 739743.
Mesholam, R.I., Moberg, P.J., Mahr, R.N., Doty, R.L., 1998. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Archives of Neurology 55, 8490.
Meusel, T., Westermann, B., Fuhr, P., Hummel, T., Welge-Lussen, A., 2010. The course of olfactory deficits in patients with Parkinson’s disease–a study based on psychophysical and electrophysiological measures. Neuroscience Letters 486, 166170.
Mirelman, A., Alcalay, R.N., Saunders-Pullman, R., et al. 2015. Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene. Movement Disorders 30, 981986.
Mitchell, I.J., Heims, H., Neville, E.A., Rickards, H., 2005. Huntington’s disease patients show impaired perception of disgust in the gustatory and olfactory modalities. The Journal of Neuropsychiatry and Clinical Neurosciences 17, 119121.
Miwa, T., Watanabe, A., Mitsumoto, Y., et al. 2004. Olfactory impairment and Parkinson’s disease-like symptoms observed in the common marmoset following administration of 1-methyl-4-phenyl-1 2 3 6-tetrahydropyridine. Acta Otolaryngologica Suppl. (553): 8084.
Moberg, P.J., Doty, R.L., 1997. Olfactory function in Huntington’s disease patients and at-risk offspring. International Journal of Neuroscience; 89, 133139.
Moberg, P.J., McGue, C., Kanes, S.J., et al. 2007. Phenylthiocarbamide (PTC) perception in patients with schizophrenia and first-degree family members: Relationship to clinical symptomatology and psychophysical olfactory performance. Schizophrenia Research 90(1–3), 221228.
Moberg, P.J., Pearlson, G.D., Speedie, L.J., et al. 1987. Olfactory recognition: differential impairments in early and late Huntington’s and Alzheimer’s disease. Journal of Clinical Experimental Neuropsychology 9, 650664.
Moccia, M., Picillo, M., Erro, R., et al. 2014. How does smoking affect olfaction in Parkinson’s disease? Journal of the Neurological Sciences 340(1), 215217.
Montgomery, E.B. Jr, Baker, K.B., Lyons, K., Koller, W.C., (1999) Abnormal performance on the PD test battery by asymptomatic first-degree relatives. Neurology 52, 757762.
Montgomery, E.B. Jr., Koller, W.C., LaMantia, T.J., et al. (2000) Early detection of probable idiopathic Parkinson’s disease: I. Development of a diagnostic test battery. Movement Disorders, 15, 467473.
Morgan, C.D., Murphy, C., 2002. Olfactory event-related potentials in Alzheimer’s disease. Journal of the International Neuropsychological Society 8, 753763.
Morley, J.F., Pawlowski, S.M., Kesari, A., et al. 2014. Motor and non-motor features of Parkinson’s disease that predict persistent drug-induced Parkinsonism. Parkinsonism & Related Disorders 20, 738742.
Moscovich, M., Munhoz, R.P., Teive, H.A., et al. 2012. Olfactory impairment in familial ataxias. Journal of Neurology, Neurosurgery, & Psychiatry 83, 970974.
Mueller, A., Reuner, U., Landis, B. et al. 2006. Extrapyramidal symptoms in Wilson’s disease are associated with olfactory dysfunction. Movement Disorders 21, 13111316.
Muller, A., Mungersdorf, M., Reichmann, H., Strehle, G., Hummel, T., 2002. Olfactory function in Parkinsonian syndromes. Journal of Clinical Neuroscience 9, 521524.
Mundiñano, I.C., Hernandez, M., Dicaudo, C., et al. 2013, Reduced cholinergic olfactory centrifugal inputs in patients with neurodegenerative disorders and MPTP-treated monkeys. Acta Neuropathologica 126, 411425.
Mundinano, I.C., Caballero, M.C., Ordonez, C., et al. 2011. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neuropathologica 122, 6174.
Murphy, C., Gilmore, M.M., Seery, C.S., Salmon, D.P., Lasker, BR. (1990). Olfactory thresholds are associated with degree of dementia in Alzheimer’s disease. Neurobiology of Aging 11, 465469.
Murphy, C., Jinich, S., 1996. Olfactory dysfunction in Down’s Syndrome. Neurobio Aging, 17, 631637.
Murphy, C., Schubert, C.R., Cruickshanks, K.J., Klein, B.E., Klein, R., Nondahl, D.M., 2002. Prevalence of olfactory impairment in older adults. Jama, 288(18), 23072312.
Najim al-Din, A.S., Wriekat, A., Mubaidin, A., Dasouki, M., Hiari, M., 1994. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurologica Scandinavica 89, 347–52.
Navarro-Otano, J., Gaig, C., Muxi, A., et al. 2014. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson’s disease. Parkinsonism & Related Disorders 20, 192197.
Nee, L.E., Scott, J., Polinsky, R.J., 1993. Olfactory dysfunction in the Shy-Drager syndrome. Clinical Autonomic Research 3, 281282.
Nee, L.E., Lippa, C.F., 2001, Inherited Alzheimer’s disease PS-1 olfactory function: A 10-year follow-up study. American Journal of Alzheimer’s Disease & Other Dementias, 16, 8384.
Neudorfer, O., Giladi, N., Elstein, D., et al. 1996. Occurrence of Parkinson’s syndrome in type I Gaucher disease. QJM 89, 691694.
Neumann, J., Bras, J., Deas, E., et al. 2009. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease. Brain 132, 17831794.
Newman, R., Winans, S.S., 1980. An experimental study of the ventral striatum of the golden hamster. II Neuronal connections of the olfactory tubercle. Journal of Comparative Neurology 191, 193212.
Nijjar, R.K., Murphy, C., 2002. Olfactory impairment increases as a function of age in persons with Down syndrome. Neurobiology of Aging 23(1), 6573.
Nishioka, K., Ross, O.A., Ishii, K., et al. 2009. Expanding the clinical phenotype of SNCA duplication carriers. Movement Disorders 24, 18111819.
Nordin, S., Almkvist, O., Berglund, B., Wahlund, L.O., 1997. Olfactory dysfunction for pyridine and dementia progression in Alzheimer disease. Archives of Neurology 54, 993998.
Nordin, S., Paulsen, J.S., Murphy, C., 1995b. Sensory- and memory-mediated olfactory dysfunction in Huntington’s disease. Journal of the International Neuropsychological Society 1, 281290.
Nores, J.M., Biacabe, B., Bonfils, P., 2000. [Olfactory disorders due to medications: analysis and review of the literature]. De Medecine Interne 21, 972977.
Nosrat, C.A., 1998. Neurotrophic factors in the tongue: expression patterns, biological activity, relation to innervation and studies of neurotrophin knockout mice. Annals of the New York Academy of Sciences 855, 2849.
Noyce, A.J., Bestwick, J.P., Silveira-Moriyama, L., et al. 2014. PREDICT-PD: Identifying risk of Parkinson’s disease in the community: Methods and baseline results. Journal of Neurology, Neurosurgery, & Psychiatry 85, 3137.
Noyce, A.J., Mencacci, N.E., Schrag, A., et al. 2015. Web-based assessment of Parkinson’s prodromal markers identifies GBA variants. Movement Disorders 30, 10021003.
Noyce, A.J., R’Bibo, L., Peress, L., Bestwick, J.P., Adams‐Carr, K.L., Mencacci, N.E., Hawkes, C.H., Masters, J.M., Wood, N., Hardy, J., Giovannoni, G., 2017. PREDICT‐PD: An online approach to prospectively identify risk indicators of Parkinson’s disease. Movement Disorders 32(2), 219226.
Oakley, B., Witt, M., 2004. Building sensory receptors on the tongue. Journal of Neurocytology 33, 631646.
Okamoto, K., Hirai, S., Shoji, M., Takatama, M. 1990. Senile changes in the human olfactory bulbs. In Nagatsu, T (Ed), Basic, Clinical, and Therapeutic Aspects of Alzheimer’s and Parkinson’s Diseases. NY: Plenum Press, pp. 349352.
Oleson, S., Murphy, C., 2015. Olfactory Dysfunction in ApoE ɛ4/4 Homozygotes with Alzheimer’s Disease. Journal of Alzheimer’s Disease 46(3), 791803.
Olichney, J.M., Murphy, C., Hofstetter, C.R., et al. 2005. Anosmia is very common in the Lewy body variant of Alzheimer’s disease. JM 76, 13421347.
Oliver, C., Holland, A.J., 1986. Down’s syndrome and Alzheimer’s disease: a review. Psychological Medicine 16, 307322.
Omar, R., Mahoney, C.J., Buskley, A.H., Warren, J.D. 2013. Flavour identification in frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery, & Psychiatry 84(1), 8893.
Ondo, W.G., Lai, D., 2005. Olfaction testing in patients with tremor-dominant PD: Is this a distinct condition? Movement Disorders 20: 471475.
Oyanagi, K., The nature of the parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam and magnesium deficiency. Parkinsonism & Related Disorders 11 Suppl 1: S1723.
Paisan-Ruiz, C., Li, A., Schneider, S.A., Holton, J.L., Johnson, R., Kidd, D., Chataway, J., Bhatia, K.P., Lees, A.J., Hardy, J, Revesz, T., 2010. Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiology of Aging 33(4), 814823.
Papaioannou, N., Tooten, P.C., van Ederen, A.M., et al. 2001. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques. Amyloid 8(1), 1121.
Pardini, M., Huey, E.D., Cavanagh, A.L., Grafman, J., 2009. Olfactory function in corticobasal syndrome and frontotemporal dementia. Archives of Neurology 66, 9296.
Park, J.S., Blair, N.F., Sue, C.M., 2015. The role of ATP13A2 in Parkinson’s disease: Clinical phenotypes and molecular mechanisms. Movement Disorders 30, 770779.
Parkkinen, L., Kauppinen, T., Pirttilä, T., Autere, J.M., Alafuzoff, I. 2005. Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Annals of Neurology 57, 8291.
Paschen, L., Schmidt, N., Wolff, S., et al. 2015. The olfactory bulb volume in patients with idiopathic Parkinson’s disease. European Journal of Neurology 22, 10681073.
Paulsen, J.S., Langbehn, D.R., Stout, J.C., et al. 2008. Detection of Huntington’s disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery, & Psychiatry 79, 874880.
Pearce, R.K., Hawkes, C.H., Daniel, S.E., 1995. The anterior olfactory nucleus in Parkinson’s disease. Movement Disorders 10, 283287.
Petzold, G.C., Einhaupl, K.M., Valdueza, J.M., 2003. Persistent bitter taste as an initial symptom of amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, & Psychiatry 74, 687688.
Pirogovsky, E., Gilbert, P.E., Jacobson, M., et al. 2007. Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington’s disease. Journal of Clinical Experimental Neuropsychology 29, 395404.
Pittock, S.J., Joyce, C., O’Keane, V., et al. 2000. Rapid-onset dystonia-parkinsonism: A clinical and genetic analysis of a new kindred. Neurology 55, 991995.
Piwnica-Worms, K.E., Omar, R., Hailstone, J.C., Warren, J.D., 2010. Flavour processing in semantic dementia. Cortex 46, 761768.
Poddighe, S., Bhat, K.M., Setzu, M.D., et al. 2013. Impaired sense of smell in a Drosophila Parkinson’s model. PLoS One 8, e73156.
Politis, M., Wu, K., Molloy, S., et al. 2010. Parkinson’s disease symptoms: The patient’s perspective. Movement Disorders 25, 16461651.
Ponsen, M.M., Stoffers, D., Booij, J., et al. 2004. Idiopathic hyposmia as a preclinical sign of Parkinson’s disease. Annals of Neurology 56, 173181.
Postuma, R.B., Gagnon, J.F., Montplaisir, J., 2010. Clinical prediction of Parkinson’s disease: planning for the age of neuroprotection. Journal of Neurology, Neurosurgery, & Psychiatry 81, 10081013.
Postuma, R.B., Gagnon, J.F., Vendette, M., Desjardins, C., Montplaisir, J.Y., 2011. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Annals of Neurology 69, 811818.
Postuma, R.B., Montplaisir, J., 2010. Transcranial ultrasound and olfaction in REM sleep behavior disorder: testing predictors of Parkinson’s disease. Sleep Med 11, 339340.
Quagliato, L.B., Viana, M.A., Quagliato, E.M., Simis, S., 2009. Olfaction and essential tremor. Arquivos de Neuro-Psiquiatria 67(1), 2124.
Quinn, N.P., Rossor, M.N., Marsden, C.D., 1987. Olfactory threshold in Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 50, 8889.
Quinn, N.P., Rossor, M.N., Marsden, C.D., 1987. Olfactory threshold in Parkinson’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 50, 8889.
Rajput, A.H., Gibb, W.R., Zhong, X.H., et al. 1994. Dopa-responsive dystonia: Pathological and biochemical observations in a case. Annals of Neurology 35, 396402.
Rebeck, G.W., Hyman, B.T., 1993. Neuroanatomical connections and specific regional vulnerability in Alzheimer’s disease. Neurobiology of Aging 14(1), 4547.
Reuber, M., Al-Din, A.S., Baborie, A., Chakrabarty, A., 2001. New variant Creutzfeldt-Jakob disease presenting with loss of taste and smell. Journal of Neurology, Neurosurgery, & Psychiatry 71, 412413.
Rial, D., Castro, A.A., Machado, N., et al. 2014. Behavioral phenotyping of Parkin-deficient mice: looking for early preclinical features of Parkinson’s disease. PLoS One 9, e114216.
Ritz, B., Lee, P-C., Lassen, C.F., Arah, O.A., 2014. Parkinson disease and smoking revisited Ease of quitting is an early sign of the disease. Neurology, 83(16), 13961402.
Roberts, R.O., Christianson, T.J., Kremers, W.K., et al. 2016, Association between olfactory dysfunction and amnestic mild cognitive impairment and Alzheimer disease dementia. JAMA Neurology 73, 93101.
Roberts, E., 1986. Alzheimer’s disease may begin in the nose and may be caused by aluminosilicates. Neurobiology of Aging 7, 561567.
Rosenberg, A., Gurevich, T., Mirelman, A., et al. 2011. Multivariate features associated with presence of “severe” mutations in the GBA gene in a cohort of asymptomatic first degree relatives of patient with Parkinson’s disease. Neurology IN41.003.
Ross, G.W., Abbott, R.D., Petrovitch, H., Tanner, C.M., White, L.R., 2012. Pre-motor features of Parkinson’s disease: The Honolulu-Asia Aging Study experience. Parkinsonism and Related Disorders 18, 199202.
Ross, G.W., Petrovitch, H., Abbott, R.D., et al. 2004. Parkinsonian signs and substantia nigra neuron density in descendants elders without PD. Annals of Neurology 56, 532539.
Ross, G.W., Abbott, R.D., Petrovitch, H., et al. 2006. Association of olfactory dysfunction with incidental Lewy bodies. Movement Disorders 21, 20622067.
Ross, G.W., Petrovitch, H., Abbott, R.D., et al. 2008. Association of olfactory dysfunction with risk for future Parkinson’s disease. Annals of Neurology 63, 167173.
Royall, D.R., Chiodo, L.K., Polk, M.S., Jaramillo, C.J., 2002. Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Neuroepidemiology 21(2), 6873.
Rutty, C.J., 1996. The middle-class plaque: Epidmic polio and the Canadian State, 1936–1937. CBMH/BCHM 13, 277314.
Sabin, A.B., Olitsky, P.K., Cox, H.R., 1936. Protective action of certain chemicals against infection of monkeys with nasally instelled poliomyelitis virus. Journal of Experimental Medicine 63, 877892.
Sabin, A.B., Ward, R., 1941. The natural history of human poliomyelitis. I. Distribution of virus in nervous and non-nervous tissues. Journal of Experimental Medicine., 73, 771793.
Sagawa, M., Takao, M., Nogawa, S., et al. 2003. [Wilson’s disease associated with olfactory paranoid syndrome and idiopathic thrombocytopenic purpura]. No To Shinkei 55, 899902.
Sajjadian, A., Doty, R.L., Gutnick, D., Chirurgi, R.J., Sivak, M., Perl, D., 1994. Olfactory dysfunction in amyotrophic lateral sclerosis. Neurodegeneration 3, 153157.
Salerno-Kennedy, R., Cusack, S., Cashman, K.D., 2005. Olfactory function in people with genetic risk of dementia. Irish Journal of Medical Science Journal 174, 4650.
Salihoglu, M., Kendirli, M.T., Altundag, A., et al. 2014. The effect of obstructive sleep apnea on olfactory functions. Laryngoscope 124, 21902194.
Samaranch, L., Lorenzo-Betancor, O., Arbelo, J.M., et al. 2010. PINK1-linked parkinsonism is associated with Lewy body pathology. Brain 133, 11281142.
Sandyk, R., 1981. Olfactory hallucinations in Parkinson’s disease. South African Medical Journal 60, 950.
Satya-Murti, S., Crisostomo, E. (1988). Olfactory threshold in Friedreich’s ataxia. Muscle & nerve, 11(4), 406407.
Saunders-Pullman, R., Hagenah, J., Dhawan, V., et al. 2010. Gaucher disease ascertained through a Parkinson’s center: imaging and clinical characterization. Movement Disorders 25, 13641372.
Saunders-Pullman, R., Mirelman, A., Wang, C., et al. 2014. Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker? Annals of Clinical and Translational Neurology 1, 670678.
Saunders-Pullman, R., Stanley, K., Wang, C., et al. 2011. Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 77, 319324.
Scherfler, C., Schocke, M.F., Seppi, K., et al. 2006. Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson’s disease. Brain 129, 538542.
Schiffman, S.S., Clark, C.M., Warwick, Z.S., 1990. Gustatory and olfactory dysfunction in dementia: Not specific to Alzheimer’s disease. Neurobiology of Aging 11, 597600.
Schiffman, S.S., Graham, B.G., Sattely-Miller, E.A., Zervakis, J., Welsh-Bohmer, K., 2002. Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer’s disease. Neurobiology of Aging 23, 397404.
Schilit, N.A., Stackpole, E.E., , T.L., et al. 2015. Fragile X mental retardation protein regulates olfactory sensitivity but not odorant discrimination. Chemical Senses 40, 345350.
Schlitt, M., Chronister, R.B., Whitley, R.J., 1991. Pathogenesis and pathophysiology of viral infections of the central nervous system. In Scheld, W.M., Whitley, R.J., Durack, D.T. (Eds.), Infections of the Central Nervous System. Raven Press, pp. 718.
Schubert, C.R., Carmichael, L.L., Murphy, C., Klein, B.E., Klein, R., Cruickshanks, K.J., 2008. Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. Journal of the American Geriatrics Society 56(8), 15171521.
Schultz, E.W., Gebhardt, L.R., 1936. Prevention of intranasally inoculated poliomyelitis in monkeys by previous intranasal irrigation with chemical agents. Proceedings of the Society for Experimental Biology and Medicine 34, 133135.
Schultz, E.W., Gebhardt, L.R., 1937. Zinc sulfate prophylaxis in poliomyelitis. Journal of the American Podiatric Medical Association 108, 21822184.
Schwartz, B.S., Doty, R.L., Monroe, C., Frye, R., Barker, S., 1989. Olfactory function in chemical workers exposed to acrylate and methacrylate vapors. American Journal of Public Health 79(5), 613618.
Schwartz, B.S., Ford, D.P., Bolla, K.I., et al. 1990. Solvent-associated decrements in olfactory function in paint manufacturing workers. American Journal of Industrial Medicine 18(6), 697706.
Semchuk, K.M., Love, E.J., Lee, R.G., Parkinson’s disease and exposure to agricultural work and pesticide chemicals. Neurology 42(7), 13281335.
Serby, M., Mohan, C., Aryan, M., et al. 1996. Olfactory identification deficits in relatives of Alzheimer’s disease patients. Biological Psychiatry 39, 375377.
Shackelford, J., Pagano, J.S., Targeting of host-cell ubiquitin pathways by viruses. Essays in Biochemistry 41, 139154
Shah, M., Deeb, J., Fernando, M., et al. 2009. Abnormality of taste and smell in Parkinson’s disease. Parkinsonism & Related Disorders 15(3), 232237.
Shah, M., Findley, L.J., Muhammed, N., Hawkes, C.H., 2005.Olfaction is normal in essential tremor and can be used to distinguish it from Parkinson’s disease. Movement Disorders 20, S10.Abs: 563.
Shah, M., Muhammed, N., Findley, L.J., Hawkes, C.H., 2007. Olfactory tests in the diagnosis of essential tremor. Journal of Neurology Neurosurgery and Psychiatry. In press.
Sharer, J.D., Leon-Sarmiento, F.E., Morley, J.F., Weintraub, D., Doty, R.L., 2015. Olfactory dysfunction in Parkinson’s disease: Positive effect of cigarette smoking. Movement Disorders 30, 859862.
Sherer, T.B., Betarbet, R., Testa, C.M., et al. 2003. Mechanism of toxicity in rotenone models of Parkinson’s disease. Journal of Neuroscience 23, 1075610764.
Shi, F., Liu, B., Zhou, Y., Yu, C., Jiang, T., 2009. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer’s disease: Meta-analyses of MRI studies. Hippocampus 19, 10551064.
Shimoji, A., Miyakawa, T., Watanabe, K., et al. 1987. Wilson’s disease with extensive degeneration of cerebral white matter and cortex. The Japanese Journal of Psychiatry and Neurology 41, 709717.
Shipley, M.T., 1985. Transport of molecules from nose to brain: Transneuronal anterograde and retrograde labelling in the rat olfactory system by wheatgerm agglutin-horseradish peroxidase applied to the nasal epithelium. Brain Research Bulletin 15, 129142.
Siderowf, A., Jennings, D., Eberly, S., et al. 2012. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Movement Disorders 27, 406412.
Siderowf, A., Newberg, A., Chou, K.L., et al. 2005. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology 64, 17161720.
Sienkiewicz-Jarosz, H., Scinska, A., Kuran, W., Ryglewicz, D., Rogowski, A., Wrobel, E., Korkosz, A., Kukwa, A., Kostowski, W., Bienkowski, P., 2005. Taste responses in patients with Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry 76(1), 4046.
Sienkiewicz-Jarosz, H., Scinska, A., Swiecicki, L., et al. 2013. Sweet liking in patients with Parkinson’s disease. Journal of the Neurological Sciences 329(1–2), 1722.
Sierra, M., Sanchez-Juan, P., Martinez-Rodriguez, MI., et al. 2013. Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease. Neurology 80, 621626.
Silveira-Moriyama, L., Guedes, L.C., Kingsbury, A., et al. 2008. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 71(13), 10211026.
Silveira-Moriyama, L., Holton, J.L., Kingsbury, A., et al. 2009. Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neuroscience Letters 453, 7780.
Silveira-Moriyama, L., Hughes, G., Church, A., et al. 2010. Hyposmia in progressive supranuclear palsy. Movement Disorders 25, 570577.
Silveira-Moriyama, L., Mathias, C., Mason, L., et al. 2009, Hyposmia in pure autonomic failure. Neurology, 72, 16771681.
Silveira-Moriyama, L., Munhoz, R.P., de, J.C., et al. 2010. Olfactory heterogeneity in LRRK2 related Parkinsonism. Movement Disorders 25, 28792883.
Silveira-Moriyama, L., Munhoz, R.P., Carvalho, M.J., et al. 2010 Olfactory Loss in LRRK2 Related Parkinsonism. Neurology Suppl. Abstract P03.189
Silveira-Moriyama, L., Schwingenschuh, P., O’Donnell, A., et al. 2009. Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs). Journal of Neurology, Neurosurgery, & Psychiatry 80(7), 744748.
Silveira-Moriyama, L., Williams, D., Katzenschlager, R., Lees, A.J., 2005. Pizza, mint, and licorice: Smell testing in Parkinson’s disease in a UK population. Movement Disorders 20, S139.
Singleton, A., Gwinn-Hardy, K., Sharabi, Y., et al. 2004. Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain 127(Pt 4), 768772.
Sliger, M., Lander, T., Murphy, C., 2004. Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome. Journal of Alzheimer’s Disease 6(4), 397402.
Smith, C.A.D, Gough, A.C., Leigh, P.N., Summers, , et al. 1992. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson’ disease. Lancet 339, 13751377.
Smith, D.H., Uryu, K., Saatman, K.E., Trojanowski, J.Q., McIntosh, T.K., 2003. Protein accumulation in traumatic brain injury. NeuroMolecular Medicine 4, 5972.
Smutzer, G.S., Doty, R.L., Arnold, S.E., Trojanowski, J.Q., 2003. Olfactory system neuropathology in Alzheimer’s Disease. In Doty, R.L., (Ed.), Parkinson’s Disease and Schizophrenia. Chapter 24 in: Handbook of olfaction and gustation. Second edition. New York: Marcel Dekker.
Sobel, N., Thomason, M.E., Stappen, I., et al. 2001. An impairment in sniffing contributes to the olfactory impairment in Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America 98, 41544159.
Sommer, U., Hummel, T., Cormann, K., et al., 2004. Detection of presymptomatic Parkinson’s disease: combining smell tests, transcranial sonography and SPECT. Movement Disorders 19, 11961202.
Spiegel, J., Hellwig, D., Mollers, M.O., et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson’s disease. Brain 129(Pt 5), 11881193.
Stadlan, E., Duvoisen, R., Yahr, M., 1965. The pathology of Parkinsonism. Fifth International Congress of Neuropathologists, Zurich, Excerpta Medica., pp 569571.
Stamps, J.J., Bartoshuk, L.M., Heilman, K.M., 2013. A brief olfactory test for Alzheimer’s disease. Journal of the Neurological Sciences 333(1), 1924.
Stamps, J.J., Doty, L., Wade, C.I., Heilman, K.M., 2016. The Left versus Right Nostril Odor Detection Test for Early Alzheimer’s Disease: Increased Sample Size, Changes with Progression of Alzheimer’s, and Performance with other Neurodegenerative Diseases. Abstract. Bonita Springs, FL: Association for Chemosensory Research.
Steinbach, S., Hundt, W., Vaitl, A., et al. 2010. Taste in mild cognitive impairment and Alzheimer’s disease. Journal of Neurology 257, 238246.
Stern, M.B., Doty, R.L., Dotti, M., et al. 1994. Olfactory function in Parkinson’s disease subtypes. Neurology 44, 266268.
Stiasny-Kolster, K., Doerr, Y., Moller, J.C., et al. 2005. Combination of “idiopathic” REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128, 126137.
Strang, R.R., 1965. The association of gastro-duodenal ulceration and Parkinson’s disease. Medical Journal of Australia 52, 842843.
Svensson, E., Horvath-Puho, E., Thomsen, R.W., et al. 2015. Vagotomy and Subsequent Risk of Parkinson’s Disease. Annals of Neurology 78, 10121013.
Swan, G.E., Carmelli, D., 2002, Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology 21, 5867.
Tabaton, M., Monaco, S., Cordone, M.P., et al. 2004. Prion deposition in olfactory biopsy of sporadic Creutzfeldt–Jakob disease. Annals of Neurology 55(2), 294296.
Tabert, M.H., Liu, X., Doty, R.L., et al. 2005, A 10-item smell identification scale related to risk for Alzheimer’s disease. Annals of Neurology 58, 155160.
Takeda, T., Iijima, M., Uchihara, T., et al. 2015. TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis. Journal of Neuropathology and Experimental Neurology 74, 547556.
Talamo, B.R., Rudel, R., Kosik, K.S., et al. 1989. Pathological changes in olfactory neurons in patients with Alzheimer’s disease. Nature 23, 337(6209), 736739.
Tanner, C.M., Goldman, S.M., Aston, D.A., et al. 2002. Smoking and Parkinson’s disease in twins. Neurology 58(4), 581588.
Thomann, P.A., Dos, S.V., Seidl, U., et al. 2009. MRI-derived atrophy of the olfactory bulb and tract in mild cognitive impairment and Alzheimer’s disease. Journal of Alzheimer’s Disease 17, 213221.
Thomann, P.A., Dos, S.V., Toro, P., et al. 2009. Reduced olfactory bulb and tract volume in early Alzheimer’s disease–a MRI study. Neurobiology of Aging 30, 838841.
Tijero, B., Gomez-Esteban, J.C., Llorens, V., et al. 2010. Cardiac sympathetic denervation precedes nigrostriatal loss in the E46 K mutation of the alpha-synuclein gene (SNCA). Clinical Autonomic Research 20, 267269.
Tissingh, G., Berendse, H.W., Bergmans, P., et al. 2001. Loss of olfaction in de novo and treated Parkinson’s disease: Possible implications for early diagnosis. Movement Disorders 16(1), 4146.
Tjalve, H., Henriksson, J., 1999. Uptake of metals in the brain via olfactory pathways. Neurotoxicology 20, 181195.
Tjalve, H., Henriksson, J., Tallkvist, J., Larsson, B.S., Lindquist, N.G., 1996. Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacology & Toxicology 79, 347356.
Tomlinson, A.H., Esiri, M.M., 1983. Herpes Simplex encephalitis: Immuno-histological demonstration of spread of virus via olfactory pathways in mice. Journal of Neurological Science 60, 473484.
Toomey, J.A., 1935. Intranasal or gastrointestinal portal of entry in poliomyelitis. Science 82(2122), 200201.
Toomey, J.A., 1936. The gastrointestinal portal of entry in poliomyelitis. Jorunal of Pediatrics 8, 664675.
Travers, J.B., Akey, L.R., Chen, S.C., Rosen, S., Paulson, G., Travers, S.P., 1993. Taste preferences in Parkinson’s disease patients. Chemical Senses 18, 4755
Trojanowski, J.Q., Newman, P.D., Hill, W.D., Lee, V.M., 1991. Human olfactory epithelium in normal aging, Alzheimer’s disease, and other neurodegenerative disorders. Journal of Comparative Neurology., 310, 365376.
Tsuboi, Y., Wszolek, Z.K., Graff-Radford, N.R., Cookson, N., Dickson, D.W., 2003. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Neuropathology & Applied Neurobiology, 29, 503510.
Tyas, S.L., Manfreda, J., Strain, L.A., Montgomery, P.R., 2001. Risk factors for Alzheimer’s disease: A population-based, longitudinal study in Manitoba, Canada. International Journal of Epidemiology, 30(3), 590597.
Tysnes, O.B., Kenborg, L., Herlofson, K., et al. 2015. Does vagotomy reduce the risk of Parkinson’s disease? Annals Neurology 78, 10111012.
Tzen, K.Y., Lu, C.S., Yen, T.C., Wey, S.P., Ting, G., 2001. Differential diagnosis of Parkinson’s disease and vascular parkinsonism by (99 m)Tc-TRODAT-1. Journal of Nuclear Medicine 42(3), 408413.
Ubeda-Bañon, I., Saiz-Sanchez, D., de la Rosa-Prieto, C., et al. 2010a. Alpha-Synucleinopathy in the human olfactory system in Parkinson’s disease: Involvement of calcium-binding protein- and substance P-positive cells. Acta Neuropathologica 119, 723735.
Ubeda-Banon, I., Saiz-Sanchez, D., de la Rosa-Prieto, C., et al. 2010b. Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson’s disease: cell types involved. Movement Disorders 25, 17011707.
Ubeda-Banon, I., Saiz-Sanchez, D., de la Rosa-Prieto, C., Martinez-Marcos, A., 2012. alpha-Synuclein in the olfactory system of a mouse model of Parkinson’s disease: Correlation with olfactory projections. Brain Structure and Function 217, 447458.
Uchida, K., Kihara, N., Hashimoto, K., et al. 2003. Age-related histological changes in the canine substantia nigra. Journal of Veterinary Medical Science 65(2), 179185.
Uchiyama, T., Fukutake, T., Arai, K., Nakagawa, K., Hattori, T., 2001. Machado-Joseph disease associated with an absence of fungiform papillae on the tongue. Neurology 56, 558560.
van der Goes van Naters, W., Carlson, J.R., 2006. Insects as chemosensors of humans and crops. Nature 444(7117), 302307.
Veeriah, S., Taylor, B.S., Meng, S., et al. 2010. Somatic mutations of the Parkinson’s disease-associated gene PARK2 in glioblastoma and other human malignancies. Nature Genetics 42, 7782.
Velayudhan, L., Lovestone, S., 2009. Smell identification test as a treatment response marker in patients with Alzheimer disease receiving donepezil. Journal of Clinical Psychopharmacology 29, 387390.
Velázquez-Pérez, L., Fernandez-Ruiz, J., Díaz, R., et al. 2006. Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases Journal of Neurology 253(9), 11651169.
Vemula, S.R., Puschmann, A., Xiao, J., et al. 2013. Role of Galpha(olf) in familial and sporadic adult-onset primary dystonia. Human Molecular Genetics 22, 25102519.
Verbaan, D., Boesveldt, S., van Rooden, S.M., et al. 2008. Is olfactory impairment in Parkinson’s disease related to phenotypic or genotypic characteristics? Neurology 71, 18771882.
Vogt, B.A., Van Hoesen, G.W., Vogt, L.J., 1990. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer’s disease. Acta Neuropathologica 80(6), 581589
Vucic, S., Tian, D., Chong, P.S., et al. 2006. Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology. Brain 129(Pt 12), 33843390.
Wakabayashi, K., Takahashi, H., Ohama, E., Ikuta, F., 1990. Parkinson’s disease: An immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathologica 79, 581583.
Wakabayashi, K., Takahashi, H., 1997. Neuropathology of autonomic nervous system in Parkinson’s disease. European Neurology 38, Suppl 2, 27.
Waldton, S., 1974. Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatrica Scandinavica 50, 539547.
Warner, M.D., Peabody, C.A., Berger, P.A., 1988. Olfactory deficits in Down’s syndrome. Biological Psychiatry, 23, 836839.
Waters, C.H., Faust, P.L., Powers, J., et al. 1993. Neuropathology of lubag (x-linked dystonia parkinsonism). Movement Disorders 8, 387390.
Wenning, G.K., Shephard, B., Hawkes, C.H., et al. 1995. Olfactory function in typical parkinsonian syndromes. Acta-Neurologica Scandinavica 91, 247250.
Wesson, D.W., Levy, E., Nixon, R.A., Wilson, D.A., 2010. Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer’s disease mouse model. Journal of Neuroscience 30, 505514.
Westervelt, H.J., Carvalho, J., Duff, K., 2007. Presentation of Alzheimer’s disease in patients with and without olfactory deficits. Archives of Clinical Neuropsychology 22, 117122.
Wetter, S., Murphy, C., 2001. Apolipoprotein E epsilon4 positive individuals demonstrate delayed olfactory event-related potentials. Neurobiology of Aging 22, 439447.
Wetter, S., Peavy, G., Jacobson, M., et al. 2005. Olfactory and auditory event-related potentials in Huntington’s disease. Neuropsychology 19(4), 428436.
Wetter, S., Murphy, C., 1999. Individuals with Down’s syndrome demonstrate abnormal olfactory event-related potentials. Clinical Neurophysiology, 110, 15631569.
Wider, C., Skipper, L., Solida, A., et al. 2008. Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. Parkinsonism & Related Disorders 14, 465470.
Williams, S.S., Williams, J., Combrinck, , M., et al. 2009. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer’s disease. Journal of Neurology, Neurosurgery, & Psychiatry 80(6), 667670.
Williams, D.R., de Silva, R., Paviour, D.C., et al. 2005. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain 128, 12471258.
Wilson, R.S., Arnold, S.E.,Schneider, , J.A.,Tang, , Y., Bennett, D.A., 2007a. The relationship between cerebral Alzheimer’s disease pathology and odour identification in old age. Journal of Neurology, Neurosurgery, and Psychiatry 78, 3035.
Wilson, R.S., Schneider, J.A., Arnold, S.E., et al. 2007b. Olfactory identification and incidence of mild cognitive impairment in older age. Archives of General Psychiatry 64, 802808.
Wilson, R.S., Arnold, S.E., Schneider, J.A., et al. 2009. Olfactory impairment in presymptomatic Alzheimer’s disease. Annals of the New York Academy of Sciences 1170, 730735.
Wilson, R.S., Yu, L., Schneider, J.A., et al. 2011. Lewy bodies and olfactory dysfunction in old age. Chemical Senses 36, 367373.
Wisniewski, K.E., Wisniewski, H.M., Wen, G.Y., 1985. Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Annals of Neurology 17, 278282.
Witoonpanich, P., Cash, D.M., Shakespeare, T.J., et al. 2013. Olfactory impairment in posterior cortical atrophy. Journal of Neurology, Neurosurgery, & Psychiatry 84, 588590.
Witt, M., Bormann, K., Gudziol, V., et al. 2009. Biopsies of olfactory epithelium in patients with Parkinson’s disease. Movement Disorders 24, 906914.
Wood, N.I., Goodman, A.O., van der Burg, J.M., et al. 2008. Increased thirst and drinking in Huntington’s disease and the R6/2 mouse. Brain Research Bulletin 76, 7079.
Wu, N., Rao, X., Gao, Y., Wang, J., Xu, F., 2013. Amyloid-beta deposition and olfactory dysfunction in an Alzheimer’s disease model. Journal of Alzheimer’s Disease 37, 699712.
Yahr, M.D., Orosz, D., Purohit, D.P., 2003. Co-occurrence of essential tremor and Parkinson’s disease: Clinical study of a large kindred with autopsy findings. Parkinsonism & Related Disorders 9(4), 225231.
Yamada, M., Onodera, M., Mizuno, Y., Mochizuki, H., 2004. Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated adult mice. Neuroscience 124(1), 173181.
Yamagishi, M., Ishizuka, Y., Seki, K., 1994. Pathology of olfactory mucosa in patients with Alzheimer’s disease. Annals of Otology, Rhinology, and Laryngology 103, 421427.
Yousem, D.M., Oguz, K.K., Li, C., 2001. Imaging of the olfactory system. Seminars in Ultrasound, CT and MRI 22, 456472.
Zanusso, G., Ferrari, S., Benedetti, D., et al. 2009. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease. Annals of the New York Academy of Sciences 1170, 637643.
Zanusso, G., Ferrari, S., Cardone, F., et al. 2003. Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease. The New England Journal of Medicine 348, 711719.
Ziegler-Graham, K., Brookmeyer, R., Johnson, E., Arrighi, H.M., 2008. Worldwide variation in the doubling time of Alzheimer’s disease incidence rates. Alzheimer’s & Dementia 4(5), 316323.
Zijlmans, J.C., Thijssen, H.O., Vogels, O.J., et al. 1995. MRI in patients with suspected vascular parkinsonism. Neurology 45(12), 21832188.
Ziso, B., Williams, T.L., Walters, R.J., et al. 2015. Facial onset sensory and motor neuronopathy: Further evidence for aTDP-43 proteinopathy. Case Reports in Neurology 7, 95100.
Zucco, G.M., Negrin, N.S., 1994. Olfactory deficits in Down subjects: A link with Alzheimer’s disease. Perceptual and Motor Skills 78(2), 627631.